欧盟官方标签名称词汇表条目 29010
TRANS-ROSE KETONE-2
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 4 个有匹配的监管证据:4 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。
已检查的市场
13
有证据的市场
4
证据缺口
9
已解析的标识符
2
已解析的物质身份
CAS:23726-91-2
EC:245-842-1
成分索引记录:
TRANS-ROSE KETONE-2
化妆品功能: PERFUMING
(E)-1-(2,6,6-Trimethyl-1-cyclohexenyl)-2-buten-1-one; trans-beta-Damascone
清单限制备注: III/158
5 个匹配或报告的名称
TRANS-ROSE KETONE-2trans-Rose ketone-2trans-Rose ketone-2ξ ((E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one; trans-beta-damascone)트랜스-로즈 케톤-2trans-Rose ketone-2 ( ) (CAS No. 23726-91-2) (E)-1-(2,6,6-Trimethyl-1- cyclohexen-1-yl)-2-buten-1- one trans- -Damascone) β (trans-beta- Damascone) 14
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 未找到匹配项 | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | Restricted | 1打开记录 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 请查看每条关联记录及其确切条件。 |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Restricted | 1打开记录 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | 未找到匹配项 | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Restricted | 1打开记录 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | 请查看每条关联记录及其确切条件。 |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 1打开记录 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 请查看每条关联记录及其确切条件。 |
| Saudi Arabia SA | 未找到匹配项 | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
没有与此筛选条件匹配的市场行。
匹配的市场记录和条件
New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)化学身份与性质

CAS 23726-91-2PubChem CID 5374527
beta-DAMASCONE
4-(2,6,6-Trimethylcyclohex-1-enyl)but-2-en-4-one is an enone. — ChEBI
- IUPAC 名称
- (E)-1-(2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one
- 分子式
- C13H20O
- 分子量
- 192.30 g/mol
- 精确质量
- 192.151415257 Da
- XLogP3
- 3.5
- 拓扑极性表面积
- 17.1 Ų
- 氢键供体
- 0
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
Damasione4-(2,6,6-Trimethylcyclohex-1-enyl)but-2-en-4-one(2E)-1-(2,6,6-trimethylcyclohex-1-en-1-yl)but-2-en-1-oneJ131X1Y3REDORINONERefChem:1079676DIHYDRO FLORIFFONE B620-561-0
另有 16 个已报告名称
245-842-1E-beta-damasconedamascone(E)-beta-DamasconeFEMA 3243(E)-1-(2,6,6-Trimethylcyclohex-1-en-1-yl)but-2-en-1-oneUNII-J131X1Y3RE2-Buten-1-one, 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-(E)-1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-buten-1-one2-Buten-1-one, 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E)-2376-92-3(E)-1-(2,6,6-Trimethylcyclohex-1-enyl)-2-buten-1-oneI75J0X33Q6Rose dihydroketonetrans-beta-Damasconebeta-Damascone, (E)-
外部数据库标识符
- ChEBI:CHEBI:192137
- ChEMBL:CHEMBL4565078
- EPA DTXSID:DTXSID7051890
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定